Compare
Charles River Laboratories vs Thermo Fisher Scientific (CRL vs TMO)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Charles River Laboratories (CRL) returned +101.3% and Thermo Fisher Scientific (TMO) +22.4%; so far this year the figures are +69.2% and +19.9%.
Thermo Fisher Scientific is the larger company by market value, about 15.9 times the size of Charles River Laboratories.
On trailing earnings, CRL trades at 348.0 times and TMO at 36.6 times.
Revenue grew -1.2% at CRL and +8.3% at TMO over the last year.
CRL pays no dividend. TMO yields 0.26%.
Data as of the latest close. Not investment advice.
Relative performance
| CRL | TMO | |
|---|---|---|
| Price | $337.52 | $694.76 |
| 1-day | +7.83% | +2.63% |
| YTD | +69.20% | +19.90% |
| 1 year | +101.26% | +22.39% |
| 3 years | +101.48% | +57.50% |
| Market cap | $16.2B | $257.4B |
| P/E | 348.0 | 36.6 |
| P/S | 4.07 | 5.44 |
| P/B | 5.01 | 4.70 |
| Revenue growth | -1.20% | +8.30% |
| EPS growth | — | +9.50% |
| Gross margin % | 39.4 | 25.2 |
| Net margin % | 1.0 | 14.9 |
| ROE % | 1.2 | 12.9 |
| Debt / equity | 0.76 | 0.79 |
| FCF yield % | 2.5 | 3.0 |
| Dividend yield % | — | 0.26 |
| Beta | 1.24 | 0.67 |
| RSI (14) | 53.7 | 54.7 |
| Technical rating |